← Leaderboards
Brian S Schwartz
Johns Hopkins University
$11,115,473
Attributed
$11,115,473
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $918.8K · FY2005–22$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$11,115,473 · 7
By mechanism
R01$7,303,488 · 3
U19$2,574,244 · 1
P01$559,165 · 1
R21$479,901 · 1
P30$198,675 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Virginia M Weaver$2,656,039
- Robert P Schleimer$28,154,309
- Katherine A Moon$693,224
- Jacques Ravel$18,661,935
- Michael Alan Trush$4,292,939
Others in their field
Top investigators on “Prevalence”
- David R. Weir · University Of Michigan At Ann Arbor$318,481,235
- John M Lachin · George Washington University$137,489,385
- Taha E Taha · Johns Hopkins University$121,748,258
- David M Nathan · Massachusetts Institute Of Technology$120,651,895
- James E. Gern · University Of Wisconsin-Madison$115,433,477
- Gita Ramjee · Medical Research Council Of South Africa$89,161,330
Research focus
PrevalenceClinical ResearchNeurotoxinsAccountingGenotypeSerumMediatingCommunitiesNovel StrategiesEtiologyBaseVisitRisk FactorsBlood PressurePopulation BasedAgingApolipoprotein EHuman SubjectPennsylvaniaPrimary Health CareElectronic Health RecordEvaluationAsthmaCounty
Grant awards (21)
Integrated Health Sciences Facility Core$198,675
P30 · FY2022 · ES · contact PI
CRS Epidemiology Using New Approaches to Validation in Population-based Studies$529,731
U19 · FY2017 · AI · contact PI
CRS Epidemiology Using New Approaches to Validation in Population-based Studies$808,226
U19 · FY2016 · AI · contact PI
CRS Epidemiology Using New Approaches to Validation in Population-based Studies$549,142
U19 · FY2015 · AI · contact PI
Marcellus shale development, respiratory & reproductive outcomes in Pennsylvania$248,248
R21 · FY2015 · ES · contact PI
CRS Epidemiology Using New Approaches to Validation in Population-based Studies$687,145
U19 · FY2014 · AI · contact PI
Marcellus shale development, respiratory & reproductive outcomes in Pennsylvania$231,653
R21 · FY2014 · ES · contact PI
CRS Epidemiology Using New Approaches to Validation in Population-based Studies$559,165
P01 · FY2013 · AI · contact PI
Explaining Disparities in Cognitive Function in Seniors$434,016
R01 · FY2011 · AG · contact PI
Explaining Disparities in Cognitive Function in Seniors$575,248
R01 · FY2010 · AG · contact PI
Explaining Disparities in Cognitive Function in Seniors$568,265
R01 · FY2009 · AG · contact PI
Explaining Disparities in Cognitive Function in Seniors$470,896
R01 · FY2008 · AG · contact PI
Age, Lead, Exposure, and Neurobehavioral Decline$548,665
R01 · FY2007 · AG · contact PI
Age, Lead, Exposure, and Neurobehavioral Decline$583,581
R01 · FY2006 · AG · contact PI
Age, Lead, Exposure, and Neurobehavioral Decline$626,372
R01 · FY2005 · AG
EXPLAINING DISPARITIES IN COGNITIVE FUNCTION IN SENIORS$604,920
R01 · FY2004 · AG
EXPLAINING DISPARITIES IN COGNITIVE FUNCTION IN SENIORS$600,952
R01 · FY2003 · AG
EXPLAINING DISPARITIES IN COGNITIVE FUNCTION IN SENIORS$602,043
R01 · FY2002 · AG
EXPLAINING DISPARITIES IN COGNITIVE FUNCTION IN SENIORS$602,717
R01 · FY2001 · AG
EXPLAINING DISPARITIES IN COGNITIVE FUNCTION IN SENIORS$597,807
R01 · FY2000 · AG
EXPOSURE, DOSE, BODY BURDEN AND HEALTH EFFECTS OF LEAD$488,006
R01 · FY2000 · ES